Background

Condition Lookup

Number of Conditions: 1

Systemic Mastocytosis

Specialty: Hematology

Category: Mast Cell Disorders

Symptoms:
flushing; abdominal pain; diarrhea; anaphylaxis; bone pain; itching; skin lesions

Root Cause:
Abnormal proliferation and accumulation of mast cells in multiple organs, often driven by mutations like KIT D816V.

How it's Diagnosed: videos
Bone marrow biopsy, KIT mutation analysis, serum tryptase levels, and clinical presentation.

Treatment:
Symptom management (antihistamines, mast cell stabilizers), cytoreductive therapy for advanced cases.

Medications:
H1 and H2 antihistamines (e.g., loratadine , ranitidine), leukotriene inhibitors (e.g., montelukast ), and tyrosine kinase inhibitors (e.g., midostaurin for advanced cases).

Prevalence: How common the health condition is within a specific population.
Rare; incidence estimated at 1 in 10,000–20,000 individuals.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Genetic mutations (e.g., KIT D816V), familial mastocytosis.

Prognosis: The expected outcome or course of the condition over time.
Variable; indolent forms have a good prognosis, while aggressive forms may have significant morbidity and mortality.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Organ dysfunction, osteoporosis, anaphylaxis, and increased risk of secondary malignancies.